LncRNA FGD5‐AS1 potentiates autophagy‐associated doxorubicin resistance by regulating the miR‐154‐5p/WNT5A axis in osteosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LncRNA FGD5‐AS1 potentiates autophagy‐associated doxorubicin resistance by regulating the miR‐154‐5p/WNT5A axis in osteosarcoma

Published:2022-08-30 Issue:11 Volume:46 Page:1937-1946
ISSN:1065-6995
Container-title:Cell Biology International
language:en
Short-container-title:Cell Biology International

Author:

Fei Dan¹,Yuan Hongping²,Zhao Mingming³,Zhao Dongxu³^ORCID

Affiliation:

1. Department of Ultrasonographic China‐Japan Union Hospital of Jilin University Changchun China

2. Department of Nephrology Jilin FAW General Hospital Changchun China

3. Department of Orthopedic Surgery China‐Japan Union Hospital of Jilin University Changchun China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbin.11889

Reference40 articles.

1. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors

2. Common Musculoskeletal Tumors of Childhood and Adolescence

3. Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin

4. A Switch from Canonical to Noncanonical Wnt Signaling Mediates Drug Resistance in Colon Cancer Cells

5. Platforms for Investigating LncRNA Functions

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of LncRNA-mediated autophagy in cancer progression;Frontiers in Cell and Developmental Biology;2024-06-12

2. Osteosarcoma in a ceRNET perspective;Journal of Biomedical Science;2024-06-05

3. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA;Drug Development Research;2024-03-05

4. CircTNPO1 promotes the tumorigenesis of osteosarcoma by sequestering miR-578 to upregulate WNT5A expression;Cellular Signalling;2023-11

5. Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer;Frontiers in Pharmacology;2023-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3